Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM), Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Chemical and Preclinical Safety, Merck Healthcare KGaA, Darmstadt, Germany.
Methods Mol Biol. 2022;2425:119-131. doi: 10.1007/978-1-0716-1960-5_5.
The pharmaceutical industry would benefit from the collaboration with academic groups in the development of predictive safety models using the newest computational technologies. However, this collaboration is sometimes hampered by the handling of confidential proprietary information and different working practices in both environments. In this manuscript, we propose a strategy for facilitating this collaboration, based on the use of modeling frameworks developed for facilitating the use of sensitive data, as well as the development, interchange, hosting, and use of predictive models in production. The strategy is illustrated with a real example in which we used Flame, an open-source modeling framework developed in our group, for the development of an in silico eye irritation model. The model was based on bibliographic data, refined during the company-academic group collaboration, and enriched with the incorporation of confidential data, yielding a useful model that was validated experimentally.
制药行业将受益于与学术团体合作,利用最新的计算技术开发预测性安全模型。然而,这种合作有时会受到处理机密专有信息和两种环境中不同工作实践的阻碍。在本文中,我们提出了一种促进这种合作的策略,该策略基于使用为促进使用敏感数据而开发的建模框架,以及在生产中开发、交换、托管和使用预测模型。该策略通过一个实际示例进行了说明,我们在该示例中使用了我们小组开发的开源建模框架 Flame 来开发一种计算机模拟眼刺激模型。该模型基于文献数据,并在公司与学术团体的合作过程中进行了改进,同时还融入了机密数据,从而生成了一个经过实验验证的有用模型。